Anti-leishmanial activities of Olea europaea subsp. laperrinei extracts
Cellular and Molecular Biology · 2023
DOI: 10.14715/cmb/2023.69.3.30 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular and Molecular Biology, 2023. Verfasst von Souad Lahcene und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Analytical Biochemistry and Biotechnology (LABAB), Faculty of Biological Sciences and Agronomic Sciences. Mouloud Mammeri University, T…. Hauptthemen laut MEDLINE: Olea, Leishmania infantum. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Leishmaniasis is an infectious disease that is often fatal in affected patients and represents a major public health problem. At present, no vaccine is available, and the drug treatments used are costly, long, and have numerous side effects, they also present variable effectiveness, frequent relapses, and a more and more marked resistance towards the parasites. Thus, new therapeutic strategies are urgently needed, and they are mainly based on the research of active natural products. The objective of our study is the chemical characterization and the quantification of the polyphenol contents contained in the EAF and EAT extracts of the Laperrine olive tree and the evaluation of their antileishmania effect against Leishmania infantum. The quantification of polyphenols, flavonoids and total tannins shows a higher content in the leaf extract. We find respectively 776.76±30.64 mg gallic acid equivalent/g DR; 114.35±14.12 mg quercetin equivalent/g DR and 214.89±.17 mg tannic acid equivalent/g DR.The chemical characterization of Olea europaea subsp. laperrinei extracts show the presence of numerous antileishmanial biomolecules such as oleuropein, hydroxytyrosol, rutin, gallic acid, cafeic acid, rosmarinic acid, and quercetin.In this context, we are testing the in vitro leishmanicidal effect of Laperrine olive tree extracts. The results obtained are promising and highlight the effectiveness of the tested extracts against the promastigote form of Leishmania infantum. Indeed, the LD50 is obtained with the leaf extract at a concentration of 7.52±2.71 µl/ml.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Analytical Biochemistry and Biotechnology (LABAB), Faculty of Biological Sciences and Agronomic Sciences. Mouloud Mammeri University, Tizi-Ouzou, Algeria. souadlahcen@yahoo.fr.
- National Institute of Marine Sciences and Technologies. Monastir, Tunisia. lamiatrabelsiakremi@gmail.com.
- Kayyali Chair for Pharmaceutical Industries, Department of Pharmaceutics, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia. mbekhet@ksu.edu.sa.
- Department of Pharmaceutical Sciences, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia. hmustafa@mcst.edu.sa.
- Microbiology and Immunology Department, Faculty of Pharmacy (Girls); Al-Azhar University, Cairo 35527, Egypt. hmustafa.c@mcst.edu.sa.
- Pharmaceutical Care Department, National Guard Health Affairs, Riyadh 11426, Saudi Arabia. k-mrc@hotmail.com.
Zitieren
APA
Lahcene, S., Trabelsi, L., M Salem-Bekhit, M., Shazly, G. A., Mohammed Refat M Selim, H., Mohammed Alehaidib, S., Sebbane, H., Msela, A., Benguerba, Y., & Houali, K. (2023). Anti-leishmanial activities of Olea europaea subsp. laperrinei extracts. Cellular and Molecular Biology. https://doi.org/10.14715/cmb/2023.69.3.30
Vancouver
Lahcene S, Trabelsi L, M Salem-Bekhit M, Shazly GA, Mohammed Refat M Selim H, Mohammed Alehaidib S, et al. Anti-leishmanial activities of Olea europaea subsp. laperrinei extracts. Cellular and Molecular Biology. 2023. doi:10.14715/cmb/2023.69.3.30
BibTeX
@article{Lahcene2023,
author = {Lahcene, Souad and Trabelsi, Lamia and M Salem-Bekhit, Mounir and Shazly, Gamal A and Mohammed Refat M Selim, Heba and Mohammed Alehaidib, Soliman and Sebbane, Hillal and Msela, Amine and Benguerba, Yacine and Houali, Karim},
title = {Anti-leishmanial activities of Olea europaea subsp. laperrinei extracts},
journal = {Cellular and Molecular Biology},
year = {2023},
doi = {10.14715/cmb/2023.69.3.30}
}
EUVIMED